Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Heterozygous variants in SLC2A1 have been identified in a subset of childhood absence epilepsy patients, with five truncating or missense alleles in 50 individuals with absence epilepsy (10%) (PMID:26537434) and two variants in 26 patients with early-onset absence epilepsy (PMID:23306390), but none in 124 childhood absence epilepsy or juvenile absence cohorts (PMID:23306390). The recurrent variant c.143G>A (p.Trp48Ter) and other LoF alleles lead to haploinsufficiency of the GLUT1 transporter, impairing glucose uptake across the blood–brain barrier. Functional assays in Xenopus oocytes and patient erythrocytes have shown marked reductions in transport activity for truncating and missense mutations (PMID:10980529, PMID:11389907). However, no multigenerational segregation data are available and replication in classic childhood absence epilepsy is lacking.
Gene–Disease AssociationLimitedSeven heterozygous probands with childhood or early-onset absence epilepsy across two cohorts, with no familial segregation and inconsistent replication in CAE. Genetic EvidenceLimitedFive variants in 50 absence epilepsy probands and two in 26 EOAE cases, lacking segregation or replication in classic CAE. Functional EvidenceModerateMultiple truncating and missense SLC2A1 mutations shown to significantly reduce GLUT1‐mediated glucose transport in oocyte and cell models. |